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EDITORIAL
What’s in a Name? Psychosomatic Medicine and Biobehavioral Medicine
This issue marks the 70th anniversary of the founding of
Psychosomatic Medicine. It is also the inaugural issue for
adding, Journal of Biobehavioral Medicine as our new subti-
tle. Why, after 70 years of successful publication, does our
journal now have a subtitle? Why was this particular subtitle
chosen? And what does this change mean for the future of the
journal?
In their introductory editorial in January 1939 (1), Helen
Flanders Dunbar and her associate editors1 noted that “psy-
chosomatic medicine” was a new term that was not yet well
known in the medical community. They expressed concern
that it could lead to misconceptions and misunderstandings
unless it was clearly defined. They defined it as the study of
the “. . . interrelation [of] the psychological and physiological
aspects of all normal and abnormal bodily functions . . ..”
They rejected mind-body dualism in psychosomatic medicine,
asserting that “. . . the complex neurophysiology of mood,
instinct, and intellect differs from other physiology in degree
of complexity, but not in quality,” and that “. . . psychic and
somatic phenomena take place in the same biological system
and are probably two aspects of the same process . . ..”
The contents of the first issue of Psychosomatic Medicine
reflected this perspective, and today’s readers would find that
some of the articles in that issue concerned surprisingly con-
temporary topics.2 For example, it included an article on the
role of hostility in essential hypertension (2) and a review of
experimental research on the structure and functions of the
hypothalamus (3). Thus, from its very beginning, Psychoso-
matic Medicine has been publishing articles on the roles of the
central and peripheral nervous systems, and of psychological,
behavioral, and social variables, in the development and pro-
gression of cardiovascular disease, diabetes, obesity, cancer,
and other serious medical conditions.
While rejecting mind-body dualism, the original editors
embraced two other kinds of dualism. One of them pertained
to the types of medical conditions and outcomes that were
considered to be within the field’s and the journal’s domain. In
addition to papers on relatively “hard” medical outcomes,
such as cardiovascular disease, early volumes also included
articles on “soft” outcomes, such as conversion hysteria and
functional gastrointestinal complaints (4). In the ensuing
years, many other papers also focused on similar problems,
such as chronic pain, somatoform disorders, and unexplained
somatic symptoms, such as chronic fatigue (5).
The other kind of dualism concerned the psychiatric and
psychological factors that were thought to be plausible expla-
nations for the outcomes of interest. Some were observable
phenomena, or at least were measurable via self-report ques-
tionnaires, psychophysiological instruments, human or animal
experiments, or other objective techniques; were reasonably
familiar to nonpsychiatric physicians and laypeople; and could
be readily described in common sense terms. Examples in-
cluded factors, such as hostility (2), frustration (6), tension (7),
depression (7), and various types of overt behavior (8). Others
were unobservable psychoanalytic constructs that were more
obscure for nonpsychiatrists, such as intrapsychic conflict (9),
oral dependence (10), and hypertrophied conscience (11).
Over the years since our founding, the relatively soft and
obscure strands of psychosomatic medicine have, unfortu-
nately, helped to foster some of the misconceptions and mis-
understandings that our founders hoped to prevent. The term
“psychosomatic” has acquired a variety of meanings, and
some of them are quite negative. For example, a 1994 survey
of newspapers in the United States and the United Kingdom
found that, out of 215 articles in which the word “psychoso-
matic” was mentioned, 34% used it in a stigmatizing, pejora-
tive manner; it often connoted a symptom or condition that
was considered to be imaginary, unimportant, malingered, or
due to a character flaw (12). “Psychosomatic” also carries
negative connotations for many laypeople (13) as well as for
many physicians and nurses (14,15), especially in some coun-
tries and cultures. In addition, psychosomatic complaints fig-
ure prominently in a substantial proportion of the clinical
encounters with which many physicians would rather not have
to contend, i.e., those with “difficult patients,” “frequent at-
tenders,” and “excessive utilizers” (15–23). Some patients
who are dismissed as presenting baseless psychosomatic com-
plaints, actually have unrecognized medical conditions, such
as hypothyroidism (24), but this fact does little to burnish the
image of psychosomatic disorders among physicians.
Regardless of the negative reactions that these phenomena
may elicit from some quarters, they continue to have a sub-
stantial impact on patients’ quality of life and on their patterns
of healthcare utilization (25,26). We still publish some of the
best articles on somatoform disorders, chronic fatigue syn-
drome, chronic pain, etc. (24,27,28), and will continue to do
so. In recent years, however, interest in these disorders has
been eclipsed by “hotter” topics, in terms of the manuscripts
we receive, the ones we publish, and the ones that have the
highest impact. For example, we have published numerous
articles on the genetic substrates of psychological phenotypes,
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such as anger, stress, and depression and their relationships
with cardiovascular disease (29–34); on psychoneuroimmuno-
logical factors in medical illness (35–49); and on neuroimaging
studies of depression and other health-related manifestations of
affective dysregulation (50–52). Some of the most frequently
cited articles that have been published in this journal in recent
years concern depression, hostility, or hopelessness as predictors
of medical morbidity and mortality in heart disease, diabetes,
or cancer (53–59).
During the tenure of our current Editor-in-Chief, one of our
goals has been to increase the journal’s impact and readership
among nonpsychiatric physicians and scientists. Unfortu-
nately, the negative attitudes about most psychosomatic phe-
nomena that pervade the medical community have been a
significant impediment to achieving this goal. We have had,
for example, informal discussions with a number of nonpsy-
chiatric physicians who have never read this journal or who
have never even heard of it. When asked to guess what sorts
of articles we publish, most of the answers have focused on
somatoform disorders, difficult patients, excessive healthcare
utilization, etc.
Consequently, we decided to conduct a more systematic
survey of faculty physicians at two university medical centers
in the United States. The survey provided the respondents with
a list of some of the most highly cited articles from recent
volumes of the journal, most of which had little or nothing to
do with somatoform disorders, difficult patients, or excessive
utilization of health services. We then provided a list of three
possible titles for a journal that publishes such articles and
asked, “In your opinion, which of the following titles would
best fit a journal that publishes this type of research? Please
rank each title 1, 2, or 3 in order of your preference.” The
titles, in the order they were most frequently ranked, were
Biobehavioral Medicine, Biopsychosocial Medicine,3 and
Psychosomatic Medicine.
Around the same time, specialists in consultation-liaison
psychiatry decided to change the name of their field to psy-
chosomatic medicine, and psychosomatic medicine was des-
ignated by the American Board of Neurology and Psychiatry
as an official psychiatric subspecialty.4 Psychiatrists are one
of our core constituencies, but Psychosomatic Medicine is a
multidisciplinary journal rather than one that identifies pri-
marily with the psychiatric subspecialty of psychosomatic
medicine (in contrast to Psychosomatics, the official journal of
the Academy of Psychosomatic Medicine). Furthermore, there
is considerable overlap between the interests of subspecialists
in psychosomatic medicine and the contents of Psychosomatic
Medicine, but they are not completely identical.
The results of our survey, and the elevation of psychoso-
matic medicine to the status of an official subspecialty,
prompted us to consider changing the title of the journal, or,
alternatively, keeping the title but adding a new subtitle. It is
not easy to change the title of a scientific journal, especially
one that has been in existence for decades. Even if a new title
might be more fitting than the old one, changing it can have
adverse consequences. If implemented too abruptly, such a
change could, for example, offend some of the journal’s most
loyal subscribers and contributors, and it could cause a tem-
porary decrease in the journal’s impact factor. With that in mind,
the editors recently proposed to give Psychosomatic Medicine a
subtitle, Journal of Biobehavioral Medicine, rather than replac-
ing the former with the latter, at least for now.
“Biobehavioral” is defined in Merriam-Webster’s Medical
Dictionary as: “of, relating to, or involving the interaction of
behavior and biological processes,” and in the American
Heritage Medical Dictionary as: “of or relating to the
interrelationships among psychosocial, behavioral, and bi-
ological processes, as in the progression or treatment of a
disease.” It is not a new term; it appeared in the medical
literature in the early 1970s (60,61), and possibly even before
then. Since then, it has been used in numerous scientific
articles pertaining to the roles of stress, emotion and mood,
social isolation, behavioral patterns, personality traits, neu-
robehavioral structures and functions, genetic factors, and
other psychosocial and behavioral characteristics in conditions
such cardiovascular disease (62–72), cancer (73–75), smoking
(76), aging (77–79), and HIV/AIDS (48,80). It tends to con-
note a focus on observable or measurable independent vari-
ables, on surrogate (e.g., transient arrhythmia) or hard (e.g.,
myocardial infarction) medical outcomes, and on behavioral
(e.g., nonadherence) or biological (e.g., inflammatory) medi-
ators. In short, it is the best available adjective for some of the
best research we have been publishing, and for the kind of
articles we want to attract.
After giving our proposal due consideration, the Council of
the American Psychosomatic Society approved the new sub-
title at their fall 2008 meeting. In doing so, they helped the
Society’s journal reach out to the broader medical community,
better positioned us vis-a`-vis the new subspecialty of psycho-
somatic medicine, and took an initial step toward reconciling
the journal’s identity with its 21st century content.
Some day in the not-too-distant future, this journal may no
longer be called Psychosomatic Medicine. It may eventually
become Biobehavioral Medicine, or perhaps The Journal of
Biobehavioral Medicine. That is for a future Council to de-
cide. But regardless of what this journal calls itself, it is, and
it has been for the past 70 years, the world’s premiere journal
of biobehavioral medicine.
Note to Readers
We are interested in your reaction to our new subtitle, and
in your thoughts on whether the journal’s main title should
remain the same or eventually be changed. Please e-mail your
comments to PsychosomaticMedicine@gmail.com.
3After completing the survey, we learned that the Japanese Society of
Psychosomatic Medicine had recently launched a journal named Biopsycho-
social Medicine.
4Psychiatrists who subspecialize in psychosomatic medicine have expertise
in the diagnosis and treatment of psychiatric disorders in “complex medically
ill patients.” This definition of medical illness includes conditions such as
stroke, heart disease, and diabetes; somatoform disorders; and psychiatric
syndromes that are due to the direct, physiological effects of a medical illness.
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